Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis-Reference-Cited by-同舟云学术

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis

Published:2019-07 Issue:7 Volume:6 Page:601-609
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Furukawa Toshi A,Cipriani Andrea,Cowen Philip J,Leucht Stefan,Egger Matthias,Salanti Georgia

Funder

Promotion of Science grant-in-aid for scientific research

NIHR Research Professorship

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference26 articles.

1. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet,2018

2. Depression: the treatment and management of depression in adults (partial update of NICE clinical guideline 23),2009

3. Practice guideline for the treatment of patients with major depressive disorder, third edition;Am J Psychiatry,2010

4. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials;Bollini;Br J Psychiatry,1999

5. A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors;Hieronymus;Transl Psychiatry,2016

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the efficacy and safety of combined buspirone and venlafaxine treatment in late-life depression accompanied by cognitive impairment: A randomized controlled trial;General Hospital Psychiatry;2024-11

2. The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review;Psychiatry Research;2024-10

3. Abnormal circadian rhythm of heart rate variability and their association with symptoms in patients with major depressive disorder;Journal of Affective Disorders;2024-10

4. Group 1 Medications for Anxiety and Depression;Pediatric Psychopharmacology for Primary Care;2024-09-09

5. Scientific Autobiography of a Japanese Psychiatrist Turned Cognitive-Behavioral Therapist, Clinical Epidemiologist and Smartphone App Developer;The American Journal of Geriatric Psychiatry;2024-09